630 related articles for article (PubMed ID: 15903355)
1. The impact of age on rejection in kidney transplantation.
de Fijter JW
Drugs Aging; 2005; 22(5):433-49. PubMed ID: 15903355
[TBL] [Abstract][Full Text] [Related]
2. Increased immunogenicity and cause of graft loss of old donor kidneys.
Fijter JW; Mallat MJK; Doxiadis IIN; Ringers J; Rosendaal FR; Claas FHJ; Paul LC
J Am Soc Nephrol; 2001 Jul; 12(7):1538-1546. PubMed ID: 11423584
[TBL] [Abstract][Full Text] [Related]
3. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G
Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
[TBL] [Abstract][Full Text] [Related]
6. The UNOS renal transplant registry.
Cecka JM
Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
[TBL] [Abstract][Full Text] [Related]
7. Effect of early cyclosporine levels on kidney allograft rejection.
Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
[TBL] [Abstract][Full Text] [Related]
8. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
10. What has changed in more than 40 years of activity and 3000 kidney transplants at Policlinico University Hospital, Milan.
Berardinelli L; Raiteri M; Beretta C; Pasciucco A; Giussani A; Carini M; Marenghi C; Rossetti A; Piccolo G
Clin Transpl; 2011; ():99-110. PubMed ID: 22755406
[TBL] [Abstract][Full Text] [Related]
11. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
He X; Johnston A
Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
[TBL] [Abstract][Full Text] [Related]
12. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
[TBL] [Abstract][Full Text] [Related]
13. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M
Nephron; 1997; 75(1):20-4. PubMed ID: 9031265
[TBL] [Abstract][Full Text] [Related]
14. [Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results].
van Gelder T; Hesselink DA; Roodnat JI; Ijzermans JN; Weimar W
Ned Tijdschr Geneeskd; 2003 May; 147(20):955-9. PubMed ID: 12784528
[TBL] [Abstract][Full Text] [Related]
15. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
[TBL] [Abstract][Full Text] [Related]
16. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols.
Aiello FB; Furian L; Marino S; Marchini F; Cardillo M; De Fazio N; Rigotti P; Valente M
Int J Immunopathol Pharmacol; 2009; 22(4):1001-7. PubMed ID: 20074463
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
18. Molecular and structural consequences of early renal allograft injury.
Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
[TBL] [Abstract][Full Text] [Related]
19. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
[TBL] [Abstract][Full Text] [Related]
20. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]